Requirement for YAP1 signaling in myxoid liposarcoma

Trautmann M, Cheng Y, Jensen P, Azoitei N, Brunner I, Hüllein J, Slabicki M, Isfort I, Cyra M, Berthold R, Wardelmann E, Huss S, Altvater B, Rossig C, Hafner S, Simmet T, Ståhlberg A, Åman P, Zenz T, Lange U, Kindler T, Scholl C, Hartmann W, Fröhling S (2019)

In: EMBO Molecular Medicine, 2019.

Research article (journal)

Phosphatidylinositol-3-kinase (PI3K)/Akt signaling is functionally essential in myxoid liposarcoma

Trautmann M, Cyra M, Isfort I, Jeiler B, Krüger A, Grünewald I, Steinestel K, Altvater B, Rossig C, Hafner S (2019)

In: Molecular Cancer Therapeutics, 2019.

Research article (journal)

PD-1 checkpoint blockade in patients with relapsed AML after allogeneic stem cell transplantation

Albring J., Inselmann S., Sauer T., Schliemann C., Altvater B., Kailayangiri S., Rössig C., Hartmann W., Knorrenschild J., Sohlbach K., Groth C., Lohoff M., Neubauer A., Berdel W., Burchert A., Stelljes M. (2017)

In: Bone Marrow Transplantation, 52(2).

Research article (journal)

Control of multidrug-resistant pseudomonas aeruginosa in allogeneic hematopoietic stem cell transplant recipients by a novel bundle including remodeling of sanitary and water supply systems

Kossow A., Kampmeier S., Willems S., Berdel W., Groll A., Burckhardt B., Rossig C., Groth C., Idelevich E., Kipp F., Mellmann A., Stelljes M. (2017)

In: Clinical Infectious Diseases, 65(6).

Research article (journal)

Adoptive Therapy of Ewing Sarcoma with GD2 Antigen-Specific Car-Engineered NK Cells Induces Upregulation of Immune-Inhibitory HLA-G

Rossig C, Kailayangiri S, Altvater B, Spurny C, Jamitzky S, Schelhaas S, Wiek C, Hanenberg H, Hartmann W, Wiendl H, Meltzer J, Farwick N, Greune L (2016)

In: Pediatric Blood and Cancer, 63(3).

Research article (journal)

Publications

Contact

Top-Links

Requirement for YAP1 signaling in myxoid liposarcoma Trautmann M, Cheng Y, Jensen P, Azoitei N, Brunner I, Hüllein J, Slabicki M, Isfort I, Cyra M, Berthold R, Wardelmann E, Huss S, Altvater B, Rossig C, Hafner S, Simmet T, Ståhlberg A, Åman P, Zenz T, Lange U, Kindler T, Scholl C, Hartmann W, Fröhling S (2019) In: EMBO Molecular Medicine, 2019. Research article (journal)
SS18-SSX-dependent YAP/TAZ Signaling in Synovial Sarcoma Isfort I, Cyra M, Elges S, Kailayangiri S, Altvater B, Rossig C, Steinestel K, Grünewald I, Huss S, Eßeling E (2019) In: Clinical Cancer Research, 2019. Research article (journal)
Phosphatidylinositol-3-kinase (PI3K)/Akt signaling is functionally essential in myxoid liposarcoma Trautmann M, Cyra M, Isfort I, Jeiler B, Krüger A, Grünewald I, Steinestel K, Altvater B, Rossig C, Hafner S (2019) In: Molecular Cancer Therapeutics, 2019. Research article (journal)
Cytomegalovirus retinitis in children and adolescents with acute leukemia following allogeneic hematopoietic stem cell transplantation Zöllner SK, Herbrüggen H, Kolve H, Mihailovic N, Schubert F, Reicherts C, Rössig C, Groll AH (2019) In: Transplant Infectious Disease, 21(5). Research article (journal)
PD-1 checkpoint blockade in patients with relapsed AML after allogeneic stem cell transplantation Albring J., Inselmann S., Sauer T., Schliemann C., Altvater B., Kailayangiri S., Rössig C., Hartmann W., Knorrenschild J., Sohlbach K., Groth C., Lohoff M., Neubauer A., Berdel W., Burchert A., Stelljes M. (2017) In: Bone Marrow Transplantation, 52(2). Research article (journal)
FUS–DDIT3 fusion protein-driven IGF-IR signaling is a therapeutic target in myxoid liposarcoma Trautmann M., Menzel J., Bertling C., Cyra M., Isfort I., Steinestel K., Elges S., Grünewald I., Altvater B., Rossig C., Fröhling S., Hafner S., Simmet T., Åman P., Wardelmann E., Huss S., Hartmann W. (2017) In: Clinical Cancer Research, 23(20). Research article (journal)
Control of multidrug-resistant pseudomonas aeruginosa in allogeneic hematopoietic stem cell transplant recipients by a novel bundle including remodeling of sanitary and water supply systems Kossow A., Kampmeier S., Willems S., Berdel W., Groll A., Burckhardt B., Rossig C., Groth C., Idelevich E., Kipp F., Mellmann A., Stelljes M. (2017) In: Clinical Infectious Diseases, 65(6). Research article (journal)
Targeting Ewing sarcoma with activated and GD2-specific chimeric antigen receptor-engineered human NK cells induces upregulation of immune-inhibitory HLA-G Kailayangiri S., Altvater B., Spurny C., Jamitzky S., Schelhaas S., Jacobs A., Wiek C., Roellecke K., Hanenberg H., Hartmann W., Wiendl H., Pankratz S., Meltzer J., Farwick N., Greune L., Fluegge M., Rossig C. (2016) In: OncoImmunology, null(null). Research article (journal)
Adoptive Therapy of Ewing Sarcoma with GD2 Antigen-Specific Car-Engineered NK Cells Induces Upregulation of Immune-Inhibitory HLA-G Rossig C, Kailayangiri S, Altvater B, Spurny C, Jamitzky S, Schelhaas S, Wiek C, Hanenberg H, Hartmann W, Wiendl H, Meltzer J, Farwick N, Greune L (2016) In: Pediatric Blood and Cancer, 63(3). Research article (journal)
IMPACT OF GENTAMICIN USE ON CISPLATIN-INDUCED HEARING LOSS IN PATIENTS WITH OSTEOSARCOMA Zehnhoff-Dinnesen AA, Richter K, Parfitt R, Deuster D, Roessig C, Lanvers-Kaminsky C (2015) In: Pediatric Blood and Cancer, 62(4). Research article (journal)